These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7926521)

  • 1. Role of urokinase, its receptor, and serpins in colorectal carcinoma.
    Jessup JM
    Gastroenterology; 1994 Nov; 107(5):1555-9. PubMed ID: 7926521
    [No Abstract]   [Full Text] [Related]  

  • 2. Urokinase-dependent proteolysis in cultured colon cancer is directed by its receptor.
    Hollas W; Boyd D
    Semin Thromb Hemost; 1991 Jul; 17(3):225-30. PubMed ID: 1665585
    [No Abstract]   [Full Text] [Related]  

  • 3. Proteases and cancer invasion: from belief to certainty. AACR meeting on proteases and protease inhibitors in cancer, Nyborg, Denmark, 14-18 June 1998.
    Blasi F; Stoppelli MP
    Biochim Biophys Acta; 1999 Jan; 1423(1):R35-44. PubMed ID: 9989212
    [No Abstract]   [Full Text] [Related]  

  • 4. Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1.
    Bruckner A; Filderman AE; Kirchheimer JC; Binder BR; Remold HG
    Cancer Res; 1992 Jun; 52(11):3043-7. PubMed ID: 1375533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size.
    Abe J; Urano T; Konno H; Erhan Y; Tanaka T; Nishino N; Takada A; Nakamura S
    Cancer; 1999 Dec; 86(12):2602-11. PubMed ID: 10594855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of urokinase on cell proliferation and invasion.
    Binder BR
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):717-20. PubMed ID: 1966799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving role of uPA/uPAR system in human cancers.
    Dass K; Ahmad A; Azmi AS; Sarkar SH; Sarkar FH
    Cancer Treat Rev; 2008 Apr; 34(2):122-36. PubMed ID: 18162327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-enzymatic activities of proteases: from scepticism to reality.
    Del Rosso M; Fibbi G; Schmitt M
    Biol Chem; 2002 Jan; 383(1):1-4. PubMed ID: 11928804
    [No Abstract]   [Full Text] [Related]  

  • 9. Function of receptor-bound urokinase.
    Kirchheimer JC; Binder BR
    Semin Thromb Hemost; 1991 Jul; 17(3):246-50. PubMed ID: 1665586
    [No Abstract]   [Full Text] [Related]  

  • 10. The urokinase receptor and regulation of cell surface plasminogen activation.
    Blasi F; Behrendt N; Cubellis MV; Ellis V; Lund LR; Masucci MT; Møller LB; Olson DP; Pedersen N; Ploug M
    Cell Differ Dev; 1990 Dec; 32(3):247-53. PubMed ID: 1965953
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of antisense inhibition of Urokinase receptor on malignancy.
    Ossowski L
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():101-12. PubMed ID: 8815000
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis.
    Friess H; Cantero D; Graber H; Tang WH; Guo X; Kashiwagi M; Zimmermann A; Gold L; Korc M; Büchler MW
    Gastroenterology; 1997 Sep; 113(3):904-13. PubMed ID: 9287983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
    Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
    Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of the plasminogen activation system in kidney cancer correlates with its aggressive phenotype.
    Swiercz R; Wolfe JD; Zaher A; Jankun J
    Clin Cancer Res; 1998 Apr; 4(4):869-77. PubMed ID: 9563880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?
    Fazioli F; Blasi F
    Trends Pharmacol Sci; 1994 Jan; 15(1):25-9. PubMed ID: 8140655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of tumour metastasis.
    Meyer T; Hart IR
    Eur J Cancer; 1998 Feb; 34(2):214-21. PubMed ID: 9741324
    [No Abstract]   [Full Text] [Related]  

  • 18. Urokinase-type plasminogen activator receptor regulates leukocyte recruitment during experimental pneumococcal meningitis.
    Paul R; Winkler F; Bayerlein I; Popp B; Pfister HW; Koedel U
    J Infect Dis; 2005 Mar; 191(5):776-82. PubMed ID: 15688295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biologic role of components of the plasminogen-plasmin system.
    Kwaan HC
    Prog Cardiovasc Dis; 1992; 34(5):309-16. PubMed ID: 1531879
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of signaling through urokinase receptor and the cellular response.
    Koshelnick Y; Ehart M; Stockinger H; Binder BR
    Thromb Haemost; 1999 Aug; 82(2):305-11. PubMed ID: 10605718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.